Search for: "USA v. Abbott"
Results 61 - 80
of 176
Sorted by Relevance
|
Sort by Date
14 Aug 2009, 1:04 am
Ineos USA LLC, 2009 WL 790194, at *5 (N.D. [read post]
22 Aug 2011, 2:30 pm
Hart In Arcadia Development Co. v. [read post]
10 Dec 2015, 7:29 am
Yesterday’s oral arguments in Fisher v. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc.; Abbott Laboratories et al. v. [read post]
18 Nov 2009, 4:57 am
USA, Inc. [read post]
18 Nov 2009, 4:57 am
USA, Inc. [read post]
18 Nov 2009, 4:57 am
USA, Inc. [read post]
6 Oct 2010, 6:24 am
UVa Today, The Cavalier Daily, and the National Law Journal report on the role played by the University of Virginia’s Supreme Court clinic in representing the petitioner in Abbott v. [read post]
22 Apr 2016, 7:57 am
In The Daily Signal, Josh Siegel reports on comments by Texas governor Greg Abbott, who predicts that the Court will deadlock in the case. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
5 May 2010, 4:46 am
-Florida et al.; and Abbott Laboratories et al. v. [read post]
26 Apr 2012, 6:37 am
The Court also released an opinion yesterday in United States v. [read post]
19 Apr 2010, 1:34 pm
And with respect to the decision in Abbott Labs. v. [read post]
23 Jun 2010, 10:28 pm
Teva Pharmaceuticals USA, Inc. et al. [read post]
24 Aug 2012, 4:57 pm
USA, Inc., 566 F.3d 989, 994 (Fed. [read post]
6 Jan 2011, 9:47 am
Hansen In Vuki v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
3 Jan 2018, 5:28 pm
Welcome to Abbott & Kindermann’s 2017 Annual CEQA update. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
22 Apr 2014, 11:51 am
Abbott Labs. v. [read post]
